Seidenader Develops New Method To Verify Pierced Needle Shields
The company said that the needles of pre-filled syringes, penetrating the needle shield, put sterility of needle and product at risk, as well as endanger medical staff. A
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.